Ark Genomic Revolution Etf Analysis
ARKG Etf | USD 23.49 0.60 2.49% |
ARK Genomic Revolution is overvalued with Real Value of 21.38 and Hype Value of 23.49. The main objective of ARK Genomic etf analysis is to determine its intrinsic value, which is an estimate of what ARK Genomic Revolution is worth, separate from its market price. There are two main types of ARK Etf analysis: fundamental analysis and technical analysis.
The ARK Genomic etf is traded in the USA on BATS Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ARK Genomic's ongoing operational relationships across important fundamental and technical indicators.
ARK |
ARK Etf Analysis Notes
ARK Genomic is is formed as Regulated Investment Company in the United States. ETF is managed and operated by The Bank of NewYork Mellon Corporation. The fund has 35 constituents with avarage daily trading value of 3.7 M. The fund charges 0.75 percent management fee with a total expences of 0.75 percent of total asset. The fund holds 99.63% of assets under management (AUM) in equities. ARK Genomic Revolution last dividend was 1.054 per share. The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . Ark Genomic is traded on BATS Exchange in the United States. For more info on ARK Genomic Revolution please contact the company at NA.Sector Exposure
ARK Genomic Revolution constituents include assets from different sectors. As a result, investing in ARK Genomic lets you gain exposure to equities across multiple sectors, sub-sectors, or industries. This can reduce the risk of holding a single asset or a fund not diversified across different sectors or industries. Typically, investors would invest in ARK Genomic because they prefer to avoid the increased volatility of non-sector ETFs.
Different industry classifications and sub-sectors that are found among ARK Genomic's constituents divide the investing landscape into groups of entities that employ similar trades or provide related services. Combining these segments enables in-depth research of market dynamics to see which parts of the economy are growing or fading. In addition, sector investments offer targeted exposure to these segments, giving investors a wide variety of options to enhance their portfolios' asset allocations and adapt to market volatility.
ARK Genomic Revolution Investment Alerts
ARK Genomic generated a negative expected return over the last 90 days | |
ARK Genomic has high historical volatility and very poor performance | |
Latest headline from news.google.com: Cathie Wood sticks to bullish Tesla call, sees stock hitting 2,600 - Seeking Alpha | |
ARK Genomic Revolution created five year return of -4.0% | |
This fund holds 99.63% of its assets under management (AUM) in equities |
ARK Genomic Thematic Classifications
In addition to having ARK Genomic etf in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
![]() | Strategy ETFsUSA ETFs from Strategy clasification | |
![]() | Theme ETFsUSA ETFs from Theme clasification |
Management Efficiency
ARK Genomic's management efficiency ratios could be used to measure how well ARK Genomic manages its routine affairs as well as how well it operates its assets and liabilities.Understanding the management dynamics of ARK Genomic Revolution allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Returns 3 Y (19.34) | Returns 5 Y (4.00) | Returns 1 Y (14.42) | Total Assets 1.1 B | Returns 10 Y 1.1 |
Top ARK Genomic Revolution Etf Constituents
BLUE | Bluebird bio | Stock | |
VCYT | Veracyte | Stock | |
EXAS | EXACT Sciences | Stock | |
PSNL | Personalis | Stock | |
MCRB | Seres Therapeutics | Stock | |
BIIB | Biogen Inc | Stock | |
ARCT | Arcturus Therapeutics Holdings | Stock | |
REGN | Regeneron Pharmaceuticals | Stock | |
VRTX | Vertex Pharmaceuticals | Stock | |
NVS | Novartis AG ADR | Stock | |
CGEN | Compugen | Stock | |
PACB | Pacific Biosciences of | Stock | |
CRSP | Crispr Therapeutics AG | Stock | |
TDOC | Teladoc | Stock | |
IOVA | Iovance Biotherapeutics | Stock | |
GH | Guardant Health | Stock | |
RHHBY | Roche Holding Ltd | OTC Stock | |
TAK | Takeda Pharmaceutical Co | Stock | |
NTLA | Intellia Therapeutics | Stock | |
CDNA | Caredx Inc | Stock | |
FATE | Fate Therapeutics | Stock | |
TWST | Twist Bioscience Corp | Stock | |
INO | Inovio Pharmaceuticals | Stock | |
BMY | Bristol Myers Squibb | Stock | |
GILD | Gilead Sciences | Stock |
Institutional Etf Holders for ARK Genomic
Have you ever been surprised when a price of an equity instrument such as ARK Genomic is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ARK Genomic Revolution backward and forwards among themselves. ARK Genomic's institutional investor refers to the entity that pools money to purchase ARK Genomic's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
ADOCX | Alger Dynamic Opportunities | Mutual Fund | Long-Short Equity | |
SPEDX | Alger Dynamic Opportunities | Mutual Fund | Long-Short Equity | |
TMAT | Main Thematic Innovation | Etf | Global Small/Mid Stock | |
JAVAX | James Aggressive Allocation | Mutual Fund | Allocation--70% to 85% Equity |
Technical Drivers
As of the 26th of March, ARK Genomic shows the Mean Deviation of 2.56, coefficient of variation of (11,517), and Risk Adjusted Performance of (0.000012). ARK Genomic Revolution technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices. Please confirm ARK Genomic Revolution coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and skewness to decide if ARK Genomic Revolution is priced favorably, providing market reflects its regular price of 23.49 per share.ARK Genomic Revolution Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ARK Genomic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ARK Genomic Revolution. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
ARK Genomic Outstanding Bonds
ARK Genomic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ARK Genomic Revolution uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ARK bonds can be classified according to their maturity, which is the date when ARK Genomic Revolution has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
APTV 415 01 MAY 52 Corp BondUS00217GAC78 | View | |
APTV 325 01 MAR 32 Corp BondUS00217GAB95 | View | |
ASBBNK 1625 22 OCT 26 Corp BondUS00216LAD55 | View | |
ASBBNK 5398 29 NOV 27 Corp BondUS00216LAF04 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View |
ARK Genomic Predictive Daily Indicators
ARK Genomic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ARK Genomic etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 85356.77 | |||
Daily Balance Of Power | (0.71) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 23.7 | |||
Day Typical Price | 23.63 | |||
Price Action Indicator | (0.51) | |||
Period Momentum Indicator | (0.60) | |||
Relative Strength Index | 44.52 |
ARK Genomic Forecast Models
ARK Genomic's time-series forecasting models are one of many ARK Genomic's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ARK Genomic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About ARK Etf Analysis
Etf analysis is the technique used by a trader or investor to examine and evaluate how ARK Genomic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ARK shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as ARK Genomic. By using and applying ARK Etf analysis, traders can create a robust methodology for identifying ARK entry and exit points for their positions.
The fund is an actively-managed exchange-traded fund that will invest under normal circumstances primarily in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the funds investment theme of the genomics revolution . Ark Genomic is traded on BATS Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our etf analysis tools, you can find out how much better you can do when adding ARK Genomic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ARK Genomic Revolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in industry. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
The market value of ARK Genomic Revolution is measured differently than its book value, which is the value of ARK that is recorded on the company's balance sheet. Investors also form their own opinion of ARK Genomic's value that differs from its market value or its book value, called intrinsic value, which is ARK Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARK Genomic's market value can be influenced by many factors that don't directly affect ARK Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARK Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if ARK Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARK Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.